Tatva Chintan Pharma Chem Limited (TATVA) — Capital Reinvestment Ratio
Tatva Chintan Pharma Chem Limited (TATVA) has a Capital Reinvestment Ratio of 3.09x as of March 2025, meaning it reinvests 3% of its operating cash flow (Rs246.71 Million) in capital expenditures (Rs762.72 Million). Check how tangible is Tatva Chintan Pharma Chem Limited's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tatva Chintan Pharma Chem Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Tatva Chintan Pharma Chem Limited's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Tatva Chintan Pharma Chem Limited (TATVA) cash flow conversion.
Annual Capital Reinvestment Ratio for Tatva Chintan Pharma Chem Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Tatva Chintan Pharma Chem Limited from 2018 to 2025. See Tatva Chintan Pharma Chem Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.09x | Rs246.71 Million | Rs762.72 Million | ▲ +135.9% |
| 2024 | 1.31x | Rs980.44 Million | Rs1.29 Billion | ▼ -82.1% |
| 2023 | 7.31x | Rs277.83 Million | Rs2.03 Billion | ▲ +67.1% |
| 2022 | 4.38x | Rs203.78 Million | Rs891.57 Million | ▲ +407.4% |
| 2021 | 0.86x | Rs243.19 Million | Rs209.70 Million | ▼ -54.7% |
| 2020 | 1.90x | Rs253.12 Million | Rs481.72 Million | ▲ +43.1% |
| 2019 | 1.33x | Rs73.56 Million | Rs97.86 Million | ▼ -54.5% |
| 2018 | 2.93x | Rs104.12 Million | Rs304.61 Million | — |